Arrowstreet Capital
OME

Arrowstreet Capital’s Omega Protein OME Stock Holding History

Arrowstreet Capital’s Portfolio OME Stock Details OME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-229,577
Closed -$4.11M – 1344
2017
Q2 		$4.11M Sell
229,577
-28,008
-11% -$523K 0.01% 502
2017
Q1 		$5.17M Buy
+257,585
New +$6M 0.02% 558
2016
Q4 		– Sell
-379,325
Closed -$8.87M – 2889
2016
Q3 		$8.87M Hold
379,325
– – 0.03% 482
2016
Q2 		$7.58M Buy
379,325
+77,395
+26% +$1.44M 0.03% 488
2016
Q1 		$5.12M Buy
301,930
+92,062
+44% +$1.89M 0.02% 541
2015
Q4 		$4.66M Buy
209,868
+195,968
+1,410% +$4.08M 0.02% 566
2015
Q3 		$236K Buy
+13,900
New +$216K ﹤0.01% 1246
2014
Q2 		– Sell
-23,455
Closed -$283K – 1301
2014
Q1 		$283K Buy
+23,455
New +$269K ﹤0.01% 1049

Other funds holding OME

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FM
Fondren Management Houston, Texas $16.9M AUM 5.82% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Arrowstreet Capital's OME Position: Q3 2017 in Review

Arrowstreet Capital sold out of Omega Protein (OME) in Q3 2017, closing a stake of 229,577 shares — an estimated $4.11M sold.

Arrowstreet Capital first reported a position in OME in Q1 2014 and held it in 8 quarters. The position peaked at $8.87M in Q3 2016. 122 funds tracked by Wall St. Rank hold OME as of Q3 2017.

  • Arrowstreet Capital reported no remaining Omega Protein position as of Q3 2017 after selling out during the quarter.
  • Arrowstreet Capital sold 229,577 Omega Protein shares in Q3 2017, an estimated $4.11M.
  • Arrowstreet Capital first reported a position in Omega Protein in Q1 2014 and held it in 8 quarters.
  • Arrowstreet Capital's Omega Protein position peaked at $8.87M in Q3 2016.
  • 122 funds tracked by Wall St. Rank held Omega Protein as of Q3 2017.

Based on Arrowstreet Capital's 13F filing for Q3 2017, filed 14 Nov 2017.